TIMI 10A evaluated the pharmacokinetics, safety and efficacy of several doses of TNK-tPA among 113 patients with Acute ST Elevation MI <12 hours. MAIN RESULTS: TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial Circulation. 1997 Jan 21;95(2):351-6. PRESENTATIONS TIMI 10A Slides OTHER PUBLICATIONS Myoglobin, creatine … Continue reading TIMI 10A